ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.02
+0.15 (1.01%)
At close: Mar 19, 2026, 4:00 PM EDT
15.02
0.00 (0.00%)
After-hours: Mar 19, 2026, 5:01 PM EDT

ADMA Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,5774,3394,0581,022861276
Market Cap Growth
-11.04%6.92%297.14%18.73%211.72%34.97%
Enterprise Value
3,5064,3274,0371,113929.16327.34
Last Close Price
15.0218.2417.154.523.881.41
PE Ratio
25.0330.4021.17-34.77-11.76-2.76
Forward PE
15.7322.2425.2836.16--
PS Ratio
6.898.509.523.965.593.41
PB Ratio
7.419.0911.637.565.661.96
P/TBV Ratio
7.719.3611.967.495.051.39
P/FCF Ratio
126.31155.9636.74253.61-11.72-2.19
P/OCF Ratio
69.7386.0934.20116.11-14.46-2.46
EV/Sales Ratio
6.878.489.474.316.034.04
EV/EBITDA Ratio
17.5721.6927.4637.13-28.81-6.19
EV/EBIT Ratio
18.3222.6029.0551.43-23.60-5.61
EV/FCF Ratio
126.03155.5436.55276.13-12.66-2.60
Debt / Equity Ratio
0.160.160.241.051.020.72
Debt / EBITDA Ratio
0.400.400.574.78-4.83-1.95
Debt / FCF Ratio
2.872.870.7635.52-2.12-0.82
Net Debt / Equity Ratio
-0.02-0.02-0.060.680.460.37
Net Debt / EBITDA Ratio
-0.04-0.04-0.133.06-2.15-0.98
Net Debt / FCF Ratio
-0.28-0.28-0.1822.77-0.95-0.41
Asset Turnover
0.920.921.040.760.490.33
Inventory Turnover
1.151.151.211.010.830.77
Quick Ratio
3.543.542.761.582.602.62
Current Ratio
6.716.715.975.166.896.87
Return on Equity (ROE)
35.56%35.56%81.65%-19.67%-44.96%-74.03%
Return on Assets (ROA)
27.67%27.67%53.44%6.38%-12.60%-24.13%
Return on Invested Capital (ROIC)
38.27%38.27%77.99%9.55%-18.78%-35.61%
Return on Capital Employed (ROCE)
38.76%38.76%39.01%7.35%-14.18%-26.93%
Earnings Yield
4.18%3.29%4.72%-2.88%-8.51%-36.17%
FCF Yield
0.79%0.64%2.72%0.39%-8.53%-45.59%
Buyback Yield / Dilution
0.89%0.89%-0.06%0.03%-7.19%-43.85%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q